User: Guest  Login
Document type:
Congress; Article 
Author(s):
Ettrich, Thomas J; Ebert, Matthias; Lorenzen, Sylvie; Moehler, Markus; Vogel, Arndt; Witkowski, Lukas; Seufferlein, Thomas; Reinacher-Schick, Anke 
Title:
[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]. 
Abstract:
At ASCO 2017, and subsequently the ESMO congress 2017, a number of studies were presented which, in part, may change the present standard of therapy in gastrointestinal oncology. The German FLOT4 trial established perioperative Docetaxel, Oxaliplatin and 5-Fluorouracil (5-FU) as the new treatment standard for resectable adenocarcinoma of the gastroesophageal junction and the stomach. In hepatocellular carcinoma (HCC), two large studies did not show a survival benefit for selective internal thera...    »
 
Journal title abbreviation:
Z Gastroenterol 
Year:
2018 
Journal volume:
56 
Journal issue:
Pages contribution:
384-397 
Fulltext / DOI:
Print-ISSN:
0044-2771 
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)